Bayer CropScience (506285) Q3 24/25 earnings summary

Executive summary

• Unaudited financial results for the quarter and nine months ended December 31, 2024, were approved and reviewed by the Board and auditors.

• The business operates in a single segment, "Agri Care," and is subject to seasonality, making quarterly results not fully indicative of annual performance.

Financial highlights

• Revenue from operations for the quarter ended December 31, 2024, was ₹10,569 million, up from ₹9,549 million year-over-year.

• Profit before tax for the quarter was ₹336 million, down from ₹1,242 million year-over-year.

• Net profit for the quarter was ₹342 million, compared to ₹931 million in the same quarter last year.

• Earnings per share (EPS) for the quarter was ₹7.61, compared to ₹20.72 year-over-year.

Outlook and guidance

• The company notes that its business is seasonal, and quarterly figures may not represent the full year's performance.